1. Home
  2. ASMB vs OSPN Comparison

ASMB vs OSPN Comparison

Compare ASMB & OSPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$35.28

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$15.60

Market Cap

561.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
OSPN
Founded
2005
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
561.7M
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
ASMB
OSPN
Price
$35.28
$15.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$44.20
$16.67
AVG Volume (30 Days)
214.4K
417.5K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
4.53%
EPS Growth
91.78
28.77
EPS
N/A
0.48
Revenue
N/A
$243,180,000.00
Revenue This Year
N/A
$3.22
Revenue Next Year
$638.39
$3.16
P/E Ratio
N/A
$32.77
Revenue Growth
N/A
N/A
52 Week Low
$20.23
$10.07
52 Week High
$39.71
$18.48

Technical Indicators

Market Signals
Indicator
ASMB
OSPN
Relative Strength Index (RSI) 72.95 49.67
Support Level $25.86 $14.66
Resistance Level $39.17 $15.84
Average True Range (ATR) 1.83 0.65
MACD 0.83 -0.14
Stochastic Oscillator 97.18 10.68

Price Performance

Historical Comparison
ASMB
OSPN

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.

Share on Social Networks: